Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
To the Editor: In support of the recent article by Chambers (1), we wish to share our data on the origin of the MDA-MB-435 and M14 cell lines. Chambers claims that it is most plausible that both cell lines represent MDA-MB-435 based on two X chromosomes in the MDA-MB-435 karyotype, whereas M14 had been derived from a man (1). However, karyotyping does not discriminate between paternal and maternal alleles and thus does not exclude loss of the Y chromosome combined with reduplication of the X chromosome. We previously reported an allelotype on human breast cancer cell lines, including MDA-MB-435 (2). Our analyses did not detect Y chromosome sequences and revealed heterozygosity of polymorphic microsatellite markers at Xp, implying that MDA-MB-435 had indeed been derived from a woman. Our MDA-MB-435 cell line was obtained directly from American Type Culture Collection at passage 239 and M14 from its originator at passage 10 (3). We confirmed that the cell lines were identical by microsatellite analysis, in concordance with Rae and colleagues (4), and we also identified unique mutations in the p53 and p16 genes in both cell lines (3). Altogether, it can be concluded conclusively that MDA-MB-435 and M14 are breast cancer cell lines.The melanocytic phenotype of MDA-MB-435 may be explained by our recent molecular characterization of MDA-MB-435 and 40 other human breast cancer cell lines (3). Microarray gene expression profiling had revealed two major subgroups among thebreast cancer cell lines: luminal type and basal type. As anticipated, MDA-MB-435 was basal type, along with 14 other cell lines, and unsupervised hierarchical clustering showed strong similarity among the basal-type cell lines. It is unlikely that the 15 basal-type cell lines all are of melanocytic origin because 4 of them carry a BRCA1 mutation and 1 has the CHEK2 1100delC mutation. Also, 10 of the basal-type cell lines, including MDA-MB-435, are of the normal-like intrinsic subtype; a molecular subtype that had been defined on (uncultured) clinical breast tumors. Most interestingly, analysis of the genetic status of 27 well-known cancer genes in our collection of breast cancer cell lines identified two subtype-specific gene mutation profiles (3). The basal mutation profile involved mutations in the BRCA1, RB1, RAS, and BRAF genes and deletions of p16 and p14ARF. Particularly, the combination of mutations in p16, RB1, and RAS pathway genes is characteristic for melanoma. These results thus suggest that basal-type breast cancers may have a genetic basis similar to melanomas, explaining their melanocytic phenotype and perhaps also their rather aggressive clinical course.No potential conflicts of interest were disclosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Having already observed that three X‐specific SNP loci were also hemi‐ or homozygous, we concluded that the most likely mechanism for the observed XX karyotype was X‐chromosomal uniparental disomy, with the two X chromosomes having arisen by chromosomal duplication.34”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we then investigated the previously reported XX karyotype12, 15”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9392-8 · Cited by 374 · cited 1×
“We confirmed that the cell lines were identical by microsatellite analysis, in concordance with Rae and colleagues (4), and we also identified unique mutations in the p53 and p16 genes in both cell lines (3).”
ResultDistinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Hollestelle, A., Nagel, J. H. A., Smid, M., Lam, S., Elstrodt, F., Wasielewski, M., Ng, S. S., French, P. J., Peeters, J. K., Rozendaal, M. J., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0460-8 · Cited by 301 · cited 4×
“Most interestingly, analysis of the genetic status of 27 well-known cancer genes in our collection of breast cancer cell lines identified two subtype-specific gene mutation profiles (3).”
BackgroundResultSelf-citationMDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Chambers, A. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1528 · Cited by 218 · cited 2×
“Chambers claims that it is most plausible that both cell lines represent MDA-MB-435 based on two X chromosomes in the MDAMB-435 karyotype, whereas M14 had been derived from a man (1).”
BackgroundAllelotype of 28 human breast cancer cell lines and xenografts
Harkes, I. C., Elstrodt, F., Dinjens, W. N. M., Molier, M., Klijn, J. G. M., Berns, E., & Schutte, M. E. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601448 · Cited by 23 · cited 9×
“The melanocytic phenotype of MDA-MB-435 may be explained by our recent molecular characterization of MDA-MB-435 and 40 other human breast cancer cell lines (3).”
BackgroundSelf-citation
Cited by
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
Axup, J. Y., Bajjuri, K. M., Ritland, M., Hutchins, B. M., Kim, C. H., Kazane, S. A., Halder, R., Forsyth, J. S., Santidrian, A. F., Stafin, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211023109 · Cited by 596
Lorger, M., & Felding-Habermann, B. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090838 · Cited by 338
Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment
Leroy, B., Girard, L., Hollestelle, A., Minna, J. D., Gazdar, A. F., & Soussi, T. (2014) · Human Mutation · doi:10.1002/humu.22556 · Cited by 224
“Particularly, this type of analysis will not address the problem of the origin of a cell line as exemplified by the status of the M14 cell line [Chambers, 2009, Christgen and Lehmann, 2007, Hollestelle and Schutte, 2009, Rae et al., 2007].”
BackgroundSelf-citationMarcato, P., Dean, C. A., Liu, R., Coyle, K. M., Bydoun, M., Wallace, M., Clements, D. R., Turner, C., Mathenge, E. G., Gujar, S. A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.010 · Cited by 152
(2011) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-385859-7.00003-3 · Cited by 136
“[PubMed: 15548694] Cicek M, Samant RS, Kinter M, Welch DR, Casey G. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.”
BackgroundInfluential
Metadata
- Authors
- Hollestelle, A., & Schutte, M.
- Affiliations
- Erasmus MC (NL)
- Venue
- Cancer Research
- Published
- 2009-10-01
- Volume
- 69
- Issue
- 19
- Pages
- 7893-7893
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2109957503
- Cited by
- 38
- References
- 4
- Citations by year
- 2020: 1 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 4
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- MDA-MB-435, breast cancer cell lines, cell line origin, X chromosome loss, Y chromosome loss, microsatellite markers, basal-like breast cancer, luminal breast cancer, molecular subtypes, TP53 mutation, p16 mutation, gene expression profiling, allelotype
- MeSH terms
- Breast Neoplasms, Female, Humans, Melanoma, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma? https://app.cochat.ai/papers/10.1158/0008-5472.can-09-2396
- The paper
- Hollestelle, A., & Schutte, M. (2009). Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma? Cancer Research. https://doi.org/10.1158/0008-5472.can-09-2396
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.